The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Rhabdomyosarcoma – working out the pathways
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“MDM2 then inhibits p53 activity by binding to, and thereby concealing, its activation domain, and by targeting p53 for ubiquitinationmediated proteasomal degradation (Chen et al., 1995; Haupt et al., 1997; Kubbutat et al., 1997).”
BackgroundKo, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
MyoD or Myf-5 is required for the formation of skeletal muscle
Rudnicki, M. A., Schnegelsberg, P. N. J., Stead, R. H., Braun, T., Arnold, H.-H., & Jaenisch, R. (1993) · Cell · doi:10.1016/0092-8674(93)90621-v · Cited by 1,731
Soft-Tissue Sarcomas, Breast Cancer, and Other Neoplasms: A Familial Syndrome?
LI, F. P., & FRAUMENI, J. F. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-4-747 · Cited by 1,509
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“The functional relationship between these two is dramatically corroborated by the ®nding that p53 de®ciency rescues the lethality observed in MDM2 null embryos (Montes de Oca Luna et al., 1995; Jones et al., 1995).”
BackgroundMuscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene
Hasty, P., Bradley, A., Morris, J. H., Edmondson, D. G., Venuti, J. M., Olson, E. N., & Klein, W. H. (1993) · Nature · doi:10.1038/364501a0 · Cited by 1,364
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
Correlation of Terminal Cell Cycle Arrest of Skeletal Muscle with Induction of p21 by MyoD
Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., & Lassar, A. B. (1995) · Science · doi:10.1126/science.7863327 · Cited by 1,149
The MyoD family and myogenesis: Redundancy, networks, and thresholds
Weintraub, H. (1993) · Cell · doi:10.1016/0092-8674(93)90610-3 · Cited by 1,057 · cited 1×
“Our understanding of skeletal muscle development has been substantially enhanced by the creation and analysis of mice carrying null mutations in one or more of these myogenic regulators (reviewed by Weintraub, 1993; Arnold and Braun, 1996).”
Backgroundp53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating Cells
Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., & Elledge, S. J. (1995) · Science · doi:10.1126/science.7863329 · Cited by 1,032
Myogenin gene disruption results in perinatal lethality because of severe muscle defect
Nabeshima, Y., Hanaoka, K., Hayasaka, M., Esuml, E., Li, S., Nonaka, I., & Nabeshima, Y.-I. (1993) · Nature · doi:10.1038/364532a0 · Cited by 954
Cornelison, D. D. W., & Wold, B. J. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8721 · Cited by 935
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., Emanuel, B. S., Rovera, G., & Barr, F. G. (1993) · Nature Genetics · doi:10.1038/ng1193-230 · Cited by 892
Regulation ofp53downstream genes
El-Deiry, W. S. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0097 · Cited by 800
Early stages of chick somite development
Christ, B., & Ordahl, C. P. (1995) · Anatomy and Embryology · doi:10.1007/bf00304424 · Cited by 793
Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., & Nadal-Ginard, B. (1993) · Cell · doi:10.1016/0092-8674(93)90110-c · Cited by 729
Tumor surveillance via the ARF–p53 pathway
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 717
HGF/SF Is Present in Normal Adult Skeletal Muscle and Is Capable of Activating Satellite Cells
Tatsumi, R., Anderson, J. E., Nevoret, C. J., Halevy, O., & Allen, R. E. (1998) · Developmental Biology · doi:10.1006/dbio.1997.8803 · Cited by 686
Emerging Multipotent Aspects of Hepatocyte Growth Factor
Matsumoto, K., & Nakamura, T. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021283 · Cited by 660
Prives, C. (1998) · Cell · doi:10.1016/s0092-8674(00)81774-2 · Cited by 623
Interaction between the retinoblastoma protein and the oncoprotein MDM2
Xiao, Z.-X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J., Sellers, W. R., & Livingston, D. M. (1995) · Nature · doi:10.1038/375694a0 · Cited by 587
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Davis, R. J., D’Cruz, C. M., Lovell, M. A., Biegel, J. A., & Barr, F. G. (1994) · PubMed · Cited by 585
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma
Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., & Emanuel, B. S. (1993) · Nature Genetics · doi:10.1038/ng0293-113 · Cited by 555
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542
Münsterberg, A. E., Kitajewski, J., Bumcrot, D. A., McMahon, A. P., & Lassar, A. B. (1995) · Genes & Development · doi:10.1101/gad.9.23.2911 · Cited by 511
Bober, E., Franz, T., Arnold, H.-H., Gruss, P., & Tremblay, P. (1994) · Development · doi:10.1242/dev.120.3.603 · Cited by 507
Regulation of Pax-3 expression in the dermomyotome and its role in muscle development
Goulding, M., Lumsden, A., & Paquette, A. J. (1994) · Development · doi:10.1242/dev.120.4.957 · Cited by 495
Inhibition of Myogenic Differentiation in Proliferating Myoblasts by Cyclin D1-Dependent Kinase
Skapek, S. X., Rhee, J., Spicer, D. B., & Lassar, A. B. (1995) · Science · doi:10.1126/science.7863328 · Cited by 477
Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome
Hahn, H., Wojnowski, L., Zimmer, A. M., Hall, J., Miller, G., & Zimmer, A. (1998) · Nature Medicine · doi:10.1038/nm0598-619 · Cited by 452
Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., & Merlino, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.701 · Cited by 440
Self-citationTransducing Hedgehog: the story so far
Ingham, P. W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3505 · Cited by 436
Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro
Allen, R. E., Sheehan, S. M., Taylor, R. G., Kendall, T. L., & Rice, G. M. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650211 · Cited by 423
Interplay between proliferation and differentiation within the myogenic lineage
Olson, E. N. (1992) · Developmental Biology · doi:10.1016/0012-1606(92)90066-p · Cited by 423
Guo, K., Wang, J., Andrés, V., Smith, R. C., & Walsh, K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3823 · Cited by 423
Ectopic Pax-3 Activates MyoD and Myf-5 Expression in Embryonic Mesoderm and Neural Tissue
Maroto, M., Reshef, R., Münsterberg, A. E., Koester, S., Goulding, M., & Lassar, A. B. (1997) · Cell · doi:10.1016/s0092-8674(00)80190-7 · Cited by 421
Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90555-3 · Cited by 406
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
Jones, S. N., Hancock, A. R., Vogel, H., Donehower, L. A., & Bradley, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15608 · Cited by 386
Dagher, R., & Helman, L. (1999) · The Oncologist · doi:10.1634/theoncologist.4-1-34 · Cited by 382
Self-citationPax3 modulates expression of the c-Met receptor during limb muscle development.
Epstein, J. A., Shapiro, D. N., Cheng, J., Lam, P. Y., & Maas, R. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4213 · Cited by 368
Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.
Khatib, Z. A., Matsushime, H., Valentine, M. B., Shapiro, D. N., Sherr, C. J., & Look, A. T. (1993) · PubMed · Cited by 338
(1999) · PubMed · Cited by 338
A role for FGF-6 in skeletal muscle regeneration
Floss, T., Arnold, H.-H., & Braun, T. (1997) · Genes & Development · doi:10.1101/gad.11.16.2040 · Cited by 330
Missero, C., Calautti, E., Eckner, R., Chin, J., Tsai, L. H., Livingston, D. M., & Dotto, G. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5451 · Cited by 328
The role of SF/HGF and c-Met in the development of skeletal muscle
Dietrich, S., Abou-Rebyeh, F., Brohmann, H., Bladt, F., Sonnenberg-Riethmacher, E., Yamaai, T., Lumsden, A., Brand-Saberi, B., & Birchmeier, C. (1999) · Development · doi:10.1242/dev.126.8.1621 · Cited by 328
Uncoupling of Grb2 from the Met Receptor In Vivo Reveals Complex Roles in Muscle Development
Maina, F., Casagranda, F., Audero, E., Simeone, A., Comoglio, P. M., Klein, R., & Ponzetto, C. (1996) · Cell · doi:10.1016/s0092-8674(00)81372-0 · Cited by 311
Buckingham, M. (1992) · Trends in Genetics · doi:10.1016/0168-9525(92)90081-e · Cited by 309
Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G., & Rauscher, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1522 · Cited by 305
Novitch, B. G., Mulligan, G. J., Jacks, T., & Lassar, A. B. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.2.441 · Cited by 304
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204976 · Cited by 288
The INK4a/ARF tumor suppressor: one gene—two products—two pathways
Chin, L., Pomerantz, J., & DePinho, R. A. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01236-5 · Cited by 288
Keegan, K. S., Holtzman, D. A., Plug, A. W., Christenson, E. R., Brainerd, E. E., Flaggs, G., Bentley, N. J., Taylor, E. M., Meyn, M. S., Moss, S. B., et al. (1996) · Genes & Development · doi:10.1101/gad.10.19.2423 · Cited by 282
Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1
Lassar, A. B., Thayer, M. J., Overell, R. W., & Weintraub, H. (1989) · Cell · doi:10.1016/0092-8674(89)90101-3 · Cited by 281
Growth factors in skeletal muscle regeneration
Husmann, I., Soulet, L., Gautron, J., Martelly, I., & Barritault, D. (1996) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00029-9 · Cited by 274
Mechanisms of p53 loss in human sarcomas.
Mulligan, L. M., Matlashewski, G. J., Scrable, H. J., & Cavenee, W. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5863 · Cited by 269
El‐Badry, O. M., Minniti, C. P., Kohn, E. C., Houghton, P. J., Daughaday, W. H., & Helman, L. J. (1990) · PubMed · Cited by 249
Self-citationPax-3 is necessary for migration but not differentiation of limb muscle precursors in the mouse
Daston, G., Lamar, E., Olivier, M., & Goulding, M. (1996) · Development · doi:10.1242/dev.122.3.1017 · Cited by 220
Zhan, S., Shapiro, D. N., & Helman, L. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117344 · Cited by 217
Self-citationRegulation of Transcription Functions of the p53 Tumor Suppressor by the mdm-2 Oncogene
Chen, J., Lin, J., & Levine, A. J. (1995) · Molecular Medicine · doi:10.1007/bf03401562 · Cited by 213
The role of p53 in tumour suppression: lessons from mouse models
Attardi, L. D., & Jacks, T. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050269 · Cited by 201
Non-Hermitian localization and delocalization
Feinberg, J., & Zee, A. (1999) · Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics · doi:10.1103/physreve.59.6433 · Cited by 197
Gal-Levi, R., Leshem, Y., Aoki, S., Nakamura, T., & Halevy, O. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00124-9 · Cited by 197
Rao, S. S., Chu, C., & Kohtz, D. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5259 · Cited by 190
Stern, H. M., Brown, A. M. C., & Hauschka, S. D. (1995) · Development · doi:10.1242/dev.121.11.3675 · Cited by 176
Anastasi, S., Giordano, S., Sthandier, O., Gambarotta, G., Maione, R., Comoglio, P., & Amati, P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.5.1057 · Cited by 172
Loh, S., Mistry, P., Kelland, L., Abel, G., & Harrap, K. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.419 · Cited by 167
Weber-Hall, S. J., Anderson, J., McManus, A. P., Abe, S., Nojima, T., Pinkerton, R., Pritchard‐Jones, K., & SHIPLEY, J. M. (1996) · PubMed · Cited by 159
Brand‐Saberi, B., Müller, T., Wilting, J., et al. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0260 · Cited by 156
Schweigerer, L., Neufeld, G., Mergia, A., Abraham, J. A., Fiddes, J. C., & Gospodarowicz, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.3.842 · Cited by 150
Skapek, S. X., Rhee, J., Kim, P. S., Novitch, B. G., & Lassar, A. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7043 · Cited by 143
Yang, X., Vogan, K. J., Gros, P., & Park, M. (1996) · Development · doi:10.1242/dev.122.7.2163 · Cited by 137
Zhang, J., Wei, Q., Zhao, X., & Paterson, B. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.926 · Cited by 137
Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a
Mitra, J., Dai, C. Y., Somasundaram, K., El‐Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 136
Zhang, L., Kashanchi, F., Zhan, Q., Zhan, S., Brady, J. N., Fornace, A. J., Seth, P. K., & Helman, L. J. (1996) · PubMed · Cited by 121
Self-citationWeber, C. O., & Virchow, R. (1854) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01936232 · Cited by 121
Lam, P. Y. P., Sublett, J. E., Hollenbach, A. D., & Roussel, M. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.594 · Cited by 111
Allelotype of pediatric rhabdomyosarcoma
Visser, M., Sijmons, C. C., Bras, J., Arceci, R. J., Godfried, M., Valentijn, L. J., Voûte, P. A., & Baas, F. (1997) · Oncogene · doi:10.1038/sj.onc.1201302 · Cited by 104
Ginsberg, J. P., Davis, R. J., Bennicelli, J. L., Nauta, L. E., & Barr, F. G. (1998) · PubMed · Cited by 103
Activation of Skeletal Muscle Satellite Cells and the Role of Fibroblast Growth Factor Receptors
Johnson, S., & Allen, R. E. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1251 · Cited by 102
Duplication of ATR inhibits MyoD, induces aneuploidy and eliminates radiation-induced G1 arrest
Smith, L. G., Liu, S. J., Goodrich, L., Jacobson, D. A., Degnin, C., Bentley, N., Carr, A. M., Flaggs, G., Keegan, K. S., Hoekstra, M. F., et al. (1998) · Nature Genetics · doi:10.1038/ng0598-39 · Cited by 91
Keleti, J., Quezado, M., Abaza, M. M., Raffeld, M. A., & Tsokos, M. (1996) · Europe PMC (PubMed Central) · Cited by 84
Besnard‐Guérin, C., Newsham, I., Winqvist, R., & Cavenee, W. K. (1996) · Human Genetics · doi:10.1007/bf02265259 · Cited by 78
Amplification of MDM2 Inhibits MyoD-Mediated Myogenesis
Fiddler, T. A., Smith, L. G., Tapscott, S. J., & Thayer, M. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.5048 · Cited by 73
Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang, W., Kumar, P., Wang, W., Epstein, J. A., Helman, L. J., Moore, J., & Kumar, S. (1998) · PubMed · Cited by 72
Self-citationRosenthal, S. M., Brown, E. J., Brunetti, A., & Goldfine, I. D. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-5-678 · Cited by 72
Iolascon, A., Faienza, M. F., Coppola, B., Rosolen, A., Basso, G., Ragione, F. D., & Schettini, F. (1996) · Genes Chromosomes and Cancer · Cited by 69
Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1.
Wang, J., Helin, K., Jin, P., & Nadal‐Ginard, B. (1995) · PubMed · Cited by 60
Inactivation of MyoD-mediated expression of p21 in tumor cell lines.
Otten, A. D., Firpo, E. J., Gerber, A. N., Brody, L. L., Roberts, J. M., & Tapscott, S. J. (1997) · PubMed · Cited by 56
The Role of Pax3 and Pax7 in Development and Cancer
Mansouri, A. (1998) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v9.i2.40 · Cited by 54
Zhang, L., Zhan, Q., Zhan, S., Kashanchi, F., Fornace, A. J., Seth, P. K., & Helman, L. J. (1998) · DNA and Cell Biology · doi:10.1089/dna.1998.17.125 · Cited by 54
Self-citationInterdependence between muscle differentiation and cell-cycle control
Maione, R., & Amati, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00036-4 · Cited by 54
Giovanni, C. D., Melani, C. C., Nanni, P., Landuzzi, L., Nicoletti, G., Frabetti, F., Griffoni, C., Colombo, M. P., & Lollini, P. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.490 · Cited by 47
N‐ras gene activation in the rd human rhabdomyosarcoma cell line
Chardin, P., Yeramian, P., Madaule, P., & Tavitian, A. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350513 · Cited by 43
MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein.
Thorburn, A. M., Walton, P. A., & Feramisco, J. R. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.7.705 · Cited by 40
The retinoblastoma tumor suppressor protein
Hinds, P. W. (1995) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(95)90057-8 · Cited by 39
Pediatric soft tissue sarcomas
Wexler, L. H., & Helman, L. J. (1994) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.44.4.211 · Cited by 38
Self-citationLozano, G., & Luna, R. M. D. O. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00037-1 · Cited by 30
Bayani, J., Thorner, P. S., Zieleńska, M., Pandita, A., Beatty, B., & Squire, J. A. (1995) · Pediatric Pathology & Laboratory Medicine · doi:10.3109/15513819509027020 · Cited by 21
Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality
Luna, R. M. D. O., Amelse, L. L., Chávez‐Reyes, A., Evans, S. C., Brugarolas, J., Jacks, T., & Lozano, G. (1997) · Nature Genetics · doi:10.1038/ng0897-336 · Cited by 20
Berner (1996) · doi:10.1002/(sici)1098-2264(199612)17:4
(1988) · doi:10.1002/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l
Cited by
Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism
Wan, X., Harkavy, B., Shen, N., Grohar, P., & Helman, L. J. (2007) · Oncogene · doi:10.1038/sj.onc.1209990 · Cited by 755
Self-citationYu, Y., Khan, J., Khanna, C., Helman, L., Meltzer, P. S., & Merlino, G. (2004) · Nature Medicine · doi:10.1038/nm966 · Cited by 525
Self-citationMechanisms of sarcoma development
Helman, L. J., & Meltzer, P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1168 · Cited by 460
Self-citationDavicioni, E., Graf Finckenstein, F., Shahbazian, V., Buckley, J. D., Triche, T. J., & Anderson, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4578 · Cited by 308
Scotlandi, K., Manara, M. C., Nicoletti, G., Lollini, P.-L., Lukas, S., Benini, S., Croci, S., Perdichizzi, S., Zambelli, D., Serra, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3192 · Cited by 299
Metadata
- Authors
- Merlino, G., & Helman, L. J.
- Venue
- Oncogene
- Published
- 1999-09-20
- Volume
- 18
- Issue
- 38
- Pages
- 5340-5348
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1992844463
- Cited by
- 271
- References
- 108
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.